Lab Anim Res.  2018 Sep;34(3):92-100. 10.5625/lar.2018.34.3.92.

Protective effect of water extract of guibi-tang against pulmonary inflammation induced by cigarette smoke and lipopolysaccharide

Affiliations
  • 1College of Veterinary Medicine (BK21 Plus Project Team), Chonnam National University, Gwangju, Korea. dvmmk79@gmail.com
  • 2K-herb Research Center, Korea Institute of Oriental Medicine, Daejeon, Korea.

Abstract

Water extract of guibi-tang (GB), a traditional Chinese, Japanese, and Korean herbal medicine, is used to treat memory impairment, insomnia, and peptic ulcers. The aim of this study was to investigate the protective effects of GB on pulmonary inflammation induced by cigarette smoke (CS) and lipopolysaccharide (LPS). C57BL/6 mice were used to develop a pulmonary inflammation model by exposing them to CS for 1 h per day for 7 days. LPS was intranasally administered to mice under mild anesthesia on day 5. GB was administered 1 h before CS exposure at doses of 50 or 100 mg/kg for 7 days. Our results showed that GB suppressed the CS and LPS induced elevation in inflammatory cell counts in the bronchoalveolar lavage fluid (BALF), with significant reductions in protein, tumor necrosis factor (TNF)-α, and interleukin (IL)-6 levels. Histological studies revealed that GB decreased the inflammatory cell infiltration into lung tissue caused by CS- and LPS-exposure. GB also significantly decreased the CS and LPS-induced expression of inducible nitric oxide synthase (iNOS) in the lung tissue. Taken together, GB effectively attenuated airway inflammation caused by CS and LPS. These results indicate that GB is a potential therapeutic herbal formula for pulmonary inflammatory disease.

Keyword

Guibi-water extract; cigarette smoke; airway inflammation; inducible nitric oxide synthase

MeSH Terms

Anesthesia
Animals
Asian Continental Ancestry Group
Bronchoalveolar Lavage Fluid
Cell Count
Herbal Medicine
Humans
Inflammation
Interleukins
Lung
Memory
Mice
Nitric Oxide Synthase Type II
Peptic Ulcer
Pneumonia*
Sleep Initiation and Maintenance Disorders
Smoke*
Tobacco Products*
Tumor Necrosis Factor-alpha
Water*
Interleukins
Nitric Oxide Synthase Type II
Smoke
Tumor Necrosis Factor-alpha
Water

Figure

  • Figure 1 Representative HPLC profiles for (A) standard mixtures and (B) GB sample at 254 nm.

  • Figure 2 GB decreased inflammatory cell counts in the BALF of CS- and LPS-exposed mice. NC: non-treated mice; CS: CS- and LPS-exposed mice; ROF: CS- and LPS-exposed mice administered roflumilast (10 mg/kg, per os); GB50 and GB100: CS- and LPS-exposed mice administered GB (50 and 100 mg/kg, per os, respectively). The values are given as means±SD. ##P<0.01 vs NC; *P<0.05 vs CS.

  • Figure 3 GB reduced the production of inflammatory cytokines caused by exposure to CS and LPS. (A) TNF-α level, (B) IL-6 level. NC: non-treated mice; CS: CS- and LPS-exposed mice; ROF: CS- and LPS-exposed mice administered roflumilast (10 mg/kg, per os); GB50 and GB100: CS- and LPS-exposed mice administered GB (50 and 100 mg/kg, per os, respectively). The values are given as means ± SD. ##P<0.01 vs NC; *P<0.05 vs CS; **P<0.01 vs CS.

  • Figure 4 GB suppressed iNOS expression in the lung tissue from CS- and LPS-exposed mice. (A) iNOS expression in the membrane, (B) iNOS expression in the lung tissue. To determine protein expression, we used five samples per group and the experiments were repeated twice. NC: non-treated mice; CS: CS- and LPS-exposed mice; ROF: CS- and LPS-exposed mice administered roflumilast (10 mg/kg, per os); GB50 and GB100: CS- and LPS-exposed mice administered GB (50 and 100 mg/kg, per os, respectively). The values are given as means±SD. ##P<0.01 vs NC; **P<0.01 vs CS.

  • Figure 5 GB attenuated inflammatory cell infiltration. NC: non-treated mice; CS: CS- and LPS-exposed mice; ROF: CS- and LPS-exposed mice administered roflumilast (10 mg/kg, per os); GB50 and GB100: CS- and LPS-exposed mice administered GB (50 and 100 mg/kg, per os, respectively). The values are given as means±SD. ##P<0.01 vs NC; *P<0.05 vs CS; **P<0.01 vs CS.


Reference

1. Scherer PM, Chen DL. Imaging Pulmonary Inflammation. J Nucl Med. 2016; 57(11):1764–1770.
Article
2. Abdul Roda M, Sadik M, Gaggar A, Hardison MT, Jablonsky MJ, Braber S, Blalock JE, Redegeld FA, Folkerts G, Jackson PL. Targeting prolyl endopeptidase with valproic acid as a potential modulator of neutrophilic inflammation. PLoS One. 2014; 9(5):e97594.
Article
3. Boskabady MH, Gholami Mhtaj L. Effect of the Zataria multiflora on systemic inflammation of experimental animals model of COPD. Biomed Res Int. 2014; 2014:802189.
4. Liu H, Ren J, Chen H, Huang Y, Li H, Zhang Z, Wang J. Resveratrol protects against cigarette smoke-induced oxidative damage and pulmonary inflammation. J Biochem Mol Toxicol. 2014; 28(10):465–471.
Article
5. Liu MH, Lin AH, Lee HF, Ko HK, Lee TS, Kou YR. Paeonol attenuates cigarette smoke-induced lung inflammation by inhibiting ROS-sensitive inflammatory signaling. Mediators Inflamm. 2014; 2014:651890.
Article
6. Hsiao HM, Sapinoro RE, Thatcher TH, Croasdell A, Levy EP, Fulton RA, Olsen KC, Pollock SJ, Serhan CN, Phipps RP, Sime PJ. A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation. PLoS One. 2013; 8(3):e58258.
Article
7. Nikota JK, Shen P, Morissette MC, Fernandes K, Roos A, Chu DK, Barra NG, Iwakura Y, Kolbeck R, Humbles AA, Stampfli MR. Cigarette smoke primes the pulmonary environment to IL-1α/CXCR-2-dependent nontypeable Haemophilus influenzae-exacerbated neutrophilia in mice. J Immunol. 2014; 193(6):3134–3145.
Article
8. Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med. 2011; 17(3-4):293–307.
Article
9. Berry M, Hargadon B, Morgan A, Shelley M, Richter J, Shaw D, Green RH, Brightling C, Wardlaw AJ, Pavord ID. Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J. 2005; 25(6):986–991.
Article
10. Bhattacharjee A, Prasad SK, Pal S, Maji B, Banerjee A, Das D, Bose A, Chatterjee N, Mukherjee S. Possible involvement of iNOS and TNF-α in nutritional intervention against nicotine-induced pancreatic islet cell damage. Biomed Pharmacother. 2016; 84:1727–1738.
Article
11. Lee H, Park JR, Kim EJ, Kim WJ, Hong SH, Park SM, Yang SR. Cigarette smoke-mediated oxidative stress induces apoptosis via the MAPKs/STAT1 pathway in mouse lung fibroblasts. Toxicol Lett. 2016; 240(1):140–148.
Article
12. Gupta I, Ganguly S, Rozanas CR, Stuehr DJ, Panda K. Ascorbate attenuates pulmonary emphysema by inhibiting tobacco smoke and Rtp801-triggered lung protein modification and proteolysis. Proc Natl Acad Sci USA. 2016; 113(29):E4208–E4217.
Article
13. Lee YM, Lee YR, Kim CS, Jo K, Sohn E, Kim JS, Kim J. Effect of Guibi-Tang, a Traditional Herbal Formula, on Retinal Neovascularization in a Mouse Model of Proliferative Retinopathy. Int J Mol Sci. 2015; 16(12):29900–29910.
Article
14. Lee MY, Seo CS, Kim JY, Shin HK. Genotoxicity evaluation of Guibi-Tang extract using an in vitro bacterial reverse mutation assay, chromosome aberration assay, and in vivo micronucleus test. BMC Complement Altern Med. 2014; 14:215.
Article
15. Oh MS, Huh Y, Bae H, Ahn DK, Park SK. The multi-herbal formula Guibi-tang enhances memory and increases cell proliferation in the rat hippocampus. Neurosci Lett. 2005; 379(3):205–208.
Article
16. Yim NH, Kim A, Liang C, Cho WK, Ma JY. Guibitang, a traditional herbal medicine, induces apoptotic death in A431 cells by regulating the activities of mitogen-activated protein kinases. BMC Complement Altern Med. 2014; 14:344.
Article
17. Abbott-Banner KH, Page CP. Dual PDE3/4 and PDE4 inhibitors: novel treatments for COPD and other inflammatory airway diseases. Basic Clin Pharmacol Toxicol. 2014; 114(5):365–376.
Article
18. Kubo S, Kobayashi M, Iwata M, Miyata K, Takahashi K, Shimizu Y. Anti-neutrophilic inflammatory activity of ASP3258, a novel phosphodiesterase type 4 inhibitor. Int Immunopharmacol. 2012; 12(1):59–63.
Article
19. Yoshida T, Tuder RM. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev. 2007; 87(3):1047–1082.
Article
20. John-Schuster G, Günter S, Hager K, Conlon TM, Eickelberg O, Yildirim AÖ. Inflammaging increases susceptibility to cigarette smoke-induced COPD. Oncotarget. 2016; 7(21):30068–30083.
Article
21. Leberl M, Kratzer A, Taraseviciene-Stewart L. Tobacco smoke induced COPD/emphysema in the animal model-are we all on the same page? Front Physiol. 2013; 4:91.
Article
22. Li Y, Yu G, Yuan S, Tan C, Lian P, Fu L, Hou Q, Xu B, Wang H. Cigarette Smoke-Induced Pulmonary Inflammation and Autophagy Are Attenuated in Ephx2-Deficient Mice. Inflammation. 2017; 40(2):497–510.
Article
23. D'hulst AI, Vermaelen KY, Brusselle GG, Joos GF, Pauwels RA. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J. 2005; 26(2):204–213.
24. O'Donnell R, Breen D, Wilson S, Djukanovic R. Inflammatory cells in the airways in COPD. Thorax. 2006; 61(5):448–454.
25. Rovina N, Koutsoukou A, Koulouris NG. Inflammation and immune response in COPD: where do we stand? Mediators Inflamm. 2013; 2013:413735.
Article
26. Karimi K, Sarir H, Mortaz E, Smit JJ, Hosseini H, De Kimpe SJ, Nijkamp FP, Folkerts G. Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages. Respir Res. 2006; 7:66.
Article
27. Teasdale JE, Hazell GG, Peachey AM, Sala-Newby GB, Hindmarch CC, McKay TR, Bond M, Newby AC, White SJ. Cigarette smoke extract profoundly suppresses TNFα-mediated proinflammatory gene expression through upregulation of ATF3 in human coronary artery endothelial cells. Sci Rep. 2017; 7:39945.
Article
28. Hubeau C, Kubera JE, Masek-Hammerman K, Williams CM. Interleukin-6 neutralization alleviates pulmonary inflammation in mice exposed to cigarette smoke and poly(I:C). Clin Sci (Lond). 2013; 125(10):483–493.
Article
29. Wei J, Xiong XF, Lin YH, Zheng BX, Cheng DY. Association between serum interleukin-6 concentrations and chronic obstructive pulmonary disease: a systematic review and meta-analysis. PeerJ. 2015; 3:e1199.
Article
30. He JQ, Foreman MG, Shumansky K, Zhang X, Akhabir L, Sin DD, Man SF, DeMeo DL, Litonjua AA, Silverman EK, Connett JE, Anthonisen NR, Wise RA, Paré PD, Sandford AJ. Associations of IL6 polymorphisms with lung function decline and COPD. Thorax. 2009; 64(8):698–704.
Article
31. Malerba M, Radaeli A, Olivini A, Damiani G, Ragnoli B, Montuschi P, Ricciardolo FL. Exhaled nitric oxide as a biomarker in COPD and related comorbidities. Biomed Res Int. 2014; 2014:271918.
Article
32. Hesslinger C, Strub A, Boer R, Ulrich WR, Lehner MD, Braun C. Inhibition of inducible nitric oxide synthase in respiratory diseases. Biochem Soc Trans. 2009; 37(Pt 4):886–891.
Article
33. Agustí A, Morlá M, Sauleda J, Saus C, Busquets X. NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax. 2004; 59(6):483–487.
34. Wright JL, Zhou S, Churg A. Pulmonary hypertension and vascular oxidative damage in cigarette smoke exposed eNOS(-/-) mice and human smokers. Inhal Toxicol. 2012; 24(11):732–740.
35. Li XQ, Cai LM, Liu J, Ma YL, Kong YH, Li H, Jiang M. Liquiritin suppresses UVB-induced skin injury through prevention of inflammation, oxidative stress and apoptosis through the TLR4/MyD88/NF-κB and MAPK/caspase signaling pathways. Int J Mol Med. 2018; 42(3):1445–1459.
Article
36. Guan Y, Li FF, Hong L, Yan XF, Tan GL, He JS, Dong XW, Bao MJ, Xie QM. Protective effects of liquiritin apioside on cigarette smoke-induced lung epithelial cell injury. Fundam Clin Pharmacol. 2012; 26(4):473–483.
Article
37. Xiong Y, Wang J, Yu H, Zhang X, Miao C, Ma S. The effects of nodakenin on airway inflammation, hyper-responsiveness and remodeling in a murine model of allergic asthma. Immunopharmacol Immunotoxicol. 2014; 36(5):341–348.
Article
38. Ram A, Mabalirajan U, Das M, Bhattacharya I, Dinda AK, Gangal SV, Ghosh B. Glycyrrhizin alleviates experimental allergic asthma in mice. Int Immunopharmacol. 2006; 6(9):1468–1477.
Article
39. Cai X, Wang X, Li J, Chen S. Protective effect of glycyrrhizin on myocardial ischemia/reperfusion injury-induced oxidative stress, inducible nitric oxide synthase and inflammatory reactions through high-mobility group box 1 and mitogen-activated protein kinase expression. Exp Ther Med. 2017; 14(2):1219–1226.
Article
Full Text Links
  • LAR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr